Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma

[1]  J. Waterton,et al.  Imaging tumour hypoxia with oxygen-enhanced MRI and BOLD MRI. , 2019, The British journal of radiology.

[2]  M. Ng,et al.  Intensity-modulated Radiotherapy for Anal Cancer: Dose-Volume Relationship of Acute Gastrointestinal Toxicity and Disease Outcomes. , 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

[3]  D. Tait,et al.  Intensity-modulated Radiotherapy and Anal Cancer: Clinical Outcome and Late Toxicity Assessment. , 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

[4]  Clarence K. Wong,et al.  Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  J. Engelbach,et al.  O2‐sensitive MRI distinguishes brain tumor versus radiation necrosis in murine models , 2016, Magnetic Resonance in Medicine.

[6]  Geoff J M Parker,et al.  Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models. , 2016, Cancer research.

[7]  Jesús Pacheco-Torres,et al.  Dynamic oxygen challenge evaluated by NMR T1 and T2* – insights into tumor oxygenation , 2015, NMR in biomedicine.

[8]  L. Dawson,et al.  Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer. , 2014, International journal of radiation oncology, biology, physics.

[9]  R. Muirhead,et al.  Anal cancer: developing an intensity-modulated radiotherapy solution for ACT2 fractionation. , 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

[10]  Timothy Solberg,et al.  Correlations of noninvasive BOLD and TOLD MRI with pO2 and relevance to tumor radiation response , 2014, Magnetic resonance in medicine.

[11]  P. Neven,et al.  29PA NEGATIVE PROGESTERONE RECEPTOR IN LUMINAL HER-2 NEGATIVE BREAST CANCER BY AGE AT DIAGNOSIS: 10 YEARS FOLLOW-UP , 2014 .

[12]  V. Goh,et al.  Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  J. Ledermann,et al.  Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. , 2013, The Lancet. Oncology.

[14]  Charles R. Thomas,et al.  Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Mark T Lee,et al.  Twenty-five-year experience with radical chemoradiation for anal cancer. , 2012, International journal of radiation oncology, biology, physics.

[16]  J. Deasy,et al.  Radiation dose-volume effects in radiation-induced rectal injury. , 2010, International journal of radiation oncology, biology, physics.

[17]  J. Deasy,et al.  Radiation dose-volume effects and the penile bulb. , 2010, International journal of radiation oncology, biology, physics.

[18]  X Allen Li,et al.  Radiation dose-volume effects in the stomach and small bowel. , 2010, International journal of radiation oncology, biology, physics.

[19]  Geoff J M Parker,et al.  Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: a potential novel biomarker of oxygenation changes in solid tumors. , 2009, International journal of radiation oncology, biology, physics.

[20]  P. A. Gowland,et al.  Field strength dependence of R1 and R  2* relaxivities of human whole blood to prohance, vasovist, and deoxyhemoglobin , 2008, Magnetic resonance in medicine.

[21]  K. Goodman,et al.  Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning. , 2008, International journal of radiation oncology, biology, physics.

[22]  Geoff J M Parker,et al.  Organ‐specific effects of oxygen and carbogen gas inhalation on tissue longitudinal relaxation times , 2007, Magnetic resonance in medicine.

[23]  J. Ajani,et al.  Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. , 2007, International journal of radiation oncology, biology, physics.

[24]  James B. Mitchell,et al.  MR assessment of changes of tumor in response to hyperbaric oxygen treatment , 2006, Magnetic resonance in medicine.

[25]  G. Wright,et al.  Rapid high‐resolution T1 mapping by variable flip angles: Accurate and precise measurements in the presence of radiofrequency field inhomogeneity , 2006, Magnetic resonance in medicine.

[26]  David M Higgins,et al.  Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart , 2004, Magnetic resonance in medicine.

[27]  D. Rothenberger,et al.  Malignant tumors of the anal canal , 1999, Cancer.

[28]  B. Berkowitz,et al.  Role of dissolved plasma oxygen in hyperoxia-induced contrast. , 1997, Magnetic resonance imaging.

[29]  R R Edelman,et al.  Effect of oxygen inhalation on relaxation times in various tissues , 1997, Journal of magnetic resonance imaging : JMRI.

[30]  N J Pelc,et al.  Rapid calculation of T1 using variable flip angle gradient refocused imaging. , 1987, Magnetic resonance imaging.